Loading…
SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.
Also known as: NABI BIOPHARMACEUTICALS
Client-Reported Lobbying Expenses
$137K
24 filings
Firm Income Reported for This Client
$293K
Not substituted for client expenses
Summary
NABI BIOPHARMACEUTICALS is an organization, based in MD. Its political footprint includes $137K in client-reported lobbying expenses, $293K in lobbying-firm income reported for this client. Lobbying activity focuses on Health Issues, Medical/Disease Research/Clinical Labs, Medicare/Medicaid, Pharmacy. Political activity spans from 2005 to 2010.
These are different money flows and are not added together: contributions and lobbying expenses flow out, while contract awards flow to the organization.
Activity data: Senate LDA